00823nas a2200277   4500000000100000000000100001008004100002100001700043700001600060700001000076700001500086700001400101700001200115700001700127700001700144700001700161700001700178700001200195700001600207700001400223700001400237245026000251300001200511490000800523022001400531       2017                            d1 aM. Kosiborod1 aM. Cavender1 aA. Fu1 aJ. Wilding1 aK. Khunti1 aR. Holl1 aA. Norhammar1 aK. Birkeland1 aM. Jorgensen1 aM. Thuresson1 aN. Arya1 aJ. Bodegard1 aN. Hammar1 aP. Fenici00aLower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotranspo  a249-2590 v136  a0009-7322